288 related articles for article (PubMed ID: 17142102)
1. WW domain-containing oxidoreductase: a candidate tumor suppressor.
Chang NS; Hsu LJ; Lin YS; Lai FJ; Sheu HM
Trends Mol Med; 2007 Jan; 13(1):12-22. PubMed ID: 17142102
[TBL] [Abstract][Full Text] [Related]
2. p73 participates in WWOX-mediated apoptosis in leukemia cells.
Lin D; Cui Z; Kong L; Cheng F; Xu J; Lan F
Int J Mol Med; 2013 Apr; 31(4):849-54. PubMed ID: 23446842
[TBL] [Abstract][Full Text] [Related]
3. WW domain containing oxidoreductase induces apoptosis in gallbladder-derived malignant cell by upregulating expression of P73 and PUMA.
Wei D; Zhang X; Zou H; Wang L; Fu B; Wu X; Luo Z; Li X; Ge J; Li Y; Zhu H; Wang K; Wang T; Yang P; Hou Z; Wang W
Tumour Biol; 2014 Feb; 35(2):1539-50. PubMed ID: 24127039
[TBL] [Abstract][Full Text] [Related]
4. Impact of WWOX alterations on p73, ΔNp73, p53, cell proliferation and DNA ploidy in salivary gland neoplasms.
Gomes CC; Diniz MG; Oliveira CS; Tavassoli M; Odell EW; Gomez RS; De Marco L
Oral Dis; 2011 Sep; 17(6):564-71. PubMed ID: 21332605
[TBL] [Abstract][Full Text] [Related]
5. Common Chromosomal Fragile Site Gene WWOX in Metabolic Disorders and Tumors.
Li J; Liu J; Ren Y; Yang J; Liu P
Int J Biol Sci; 2014; 10(2):142-8. PubMed ID: 24520212
[TBL] [Abstract][Full Text] [Related]
6. Functional association between Wwox tumor suppressor protein and p73, a p53 homolog.
Aqeilan RI; Pekarsky Y; Herrero JJ; Palamarchuk A; Letofsky J; Druck T; Trapasso F; Han SY; Melino G; Huebner K; Croce CM
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4401-6. PubMed ID: 15070730
[TBL] [Abstract][Full Text] [Related]
7. Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.
Abu-Odeh M; Bar-Mag T; Huang H; Kim T; Salah Z; Abdeen SK; Sudol M; Reichmann D; Sidhu S; Kim PM; Aqeilan RI
J Biol Chem; 2014 Mar; 289(13):8865-80. PubMed ID: 24550385
[TBL] [Abstract][Full Text] [Related]
8. Molecular alterations in the tumor suppressor gene WWOX in oral leukoplakias.
Pimenta FJ; Cordeiro GT; Pimenta LG; Viana MB; Lopes J; Gomez MV; Aldaz CM; De Marco L; Gomez RS
Oral Oncol; 2008 Aug; 44(8):753-8. PubMed ID: 18061530
[TBL] [Abstract][Full Text] [Related]
9. WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins.
Ludes-Meyers JH; Kil H; Bednarek AK; Drake J; Bedford MT; Aldaz CM
Oncogene; 2004 Jun; 23(29):5049-55. PubMed ID: 15064722
[TBL] [Abstract][Full Text] [Related]
10. Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor.
Aqeilan RI; Palamarchuk A; Weigel RJ; Herrero JJ; Pekarsky Y; Croce CM
Cancer Res; 2004 Nov; 64(22):8256-61. PubMed ID: 15548692
[TBL] [Abstract][Full Text] [Related]
11. A p53/TIAF1/WWOX triad exerts cancer suppression but may cause brain protein aggregation due to p53/WWOX functional antagonism.
Chou PY; Lin SR; Lee MH; Schultz L; Sze CI; Chang NS
Cell Commun Signal; 2019 Jul; 17(1):76. PubMed ID: 31315632
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity.
Chang NS; Pratt N; Heath J; Schultz L; Sleve D; Carey GB; Zevotek N
J Biol Chem; 2001 Feb; 276(5):3361-70. PubMed ID: 11058590
[TBL] [Abstract][Full Text] [Related]
13. Role of WW Domain-containing Oxidoreductase WWOX in Driving T Cell Acute Lymphoblastic Leukemia Maturation.
Huang SS; Su WP; Lin HP; Kuo HL; Wei HL; Chang NS
J Biol Chem; 2016 Aug; 291(33):17319-31. PubMed ID: 27339895
[TBL] [Abstract][Full Text] [Related]
14. WW domain-containing oxidoreductase in neuronal injury and neurological diseases.
Chang HT; Liu CC; Chen ST; Yap YV; Chang NS; Sze CI
Oncotarget; 2014 Dec; 5(23):11792-9. PubMed ID: 25537520
[TBL] [Abstract][Full Text] [Related]
15. WWOX, a chromosomal fragile site gene and its role in cancer.
Ramos D; Aldaz CM
Adv Exp Med Biol; 2006; 587():149-59. PubMed ID: 17163164
[TBL] [Abstract][Full Text] [Related]
16. HGF and TGFβ1 differently influenced Wwox regulatory function on Twist program for mesenchymal-epithelial transition in bone metastatic versus parental breast carcinoma cells.
Bendinelli P; Maroni P; Matteucci E; Desiderio MA
Mol Cancer; 2015 Jun; 14():112. PubMed ID: 26041563
[TBL] [Abstract][Full Text] [Related]
17. The common fragile site FRA16D gene product WWOX: roles in tumor suppression and genomic stability.
Aqeilan RI; Abu-Remaileh M; Abu-Odeh M
Cell Mol Life Sci; 2014 Dec; 71(23):4589-99. PubMed ID: 25245215
[TBL] [Abstract][Full Text] [Related]
18. The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis.
Kuroki T; Yendamuri S; Trapasso F; Matsuyama A; Aqeilan RI; Alder H; Rattan S; Cesari R; Nolli ML; Williams NN; Mori M; Kanematsu T; Croce CM
Clin Cancer Res; 2004 Apr; 10(7):2459-65. PubMed ID: 15073125
[TBL] [Abstract][Full Text] [Related]
19. JNK1 physically interacts with WW domain-containing oxidoreductase (WOX1) and inhibits WOX1-mediated apoptosis.
Chang NS; Doherty J; Ensign A
J Biol Chem; 2003 Mar; 278(11):9195-202. PubMed ID: 12514174
[TBL] [Abstract][Full Text] [Related]
20. [Effects of WWOX gene transfection on cell growth of epithelial ovarian cancer].
Yan HC; Xue JQ; Lu XY; Wan MR; Feng X; Liu XY
Zhonghua Fu Chan Ke Za Zhi; 2008 May; 43(5):361-5. PubMed ID: 18953870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
